Skip to main content

Table 2 Summary statistics of MeDIP-seq data

From: Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer

Sample Number of total reads Number of mapped reads Total mapped read rate Number of unique reads Unique reads rate
J730 42,362,427 32,119,271 75.8% 26,454,305 82.4%
J056 29,652,736 21,442,064 72.3% 17,378,878 81.1%
J228 18,250,231 11,425,158 62.6% 9,003,634 78.8%
J474 19,015,432 10,281,561 54.1% 8,097,962 78.8%
C1 46,505,740 16,686,432 35.9% 2,089,072 12.5%
C2 18,918,360 11,095,194 58.7% 5,085,484 45.8%
C3 91,305,808 58,482,718 64.1% 8,453,424 14.5%
  1. Note: J730, J056, J228, and J474 represent patients with colorectal cancer; C1, C2, and C3 represent healthy controls